Chronic Myeloid Leukemia Drug Tasigna Associated with Arteriosclerosis and Wrongful Death.
Collect and review your records to determine whether they meet the standard for legal actions.
People suffering from Tasigna complication experience some common side effects like low blood count, rashes, tiredness, diarrhea, constipation, muscle and joint pain, etc.. Sometimes these effects get more serious like liver damage, bleeding in the brain, kidney failure, blood in urine, etc.. Who can file a Tasigna lawsuit?
Canadian regulators recently forced Tasigna’s manufacturers to warn patients of the chance of circulation problems in the arms and legs that may cause amputations.
Because of the likelihood that Tasigna peripheral arterial disease lawsuits will be consolidated to a Multi-District Litigation (MDL) in a federal court where one or more of the first Tasigna peripheral arterial disease lawsuits has been filed.
With the $390 million payment from Novartis, Kester’s lawsuit is the largest recovery to the government in a False Claims Act lawsuit based on a kickback theory, yielding a gross recovery of $465 million for the taxpayers.
Based on Haematologica (the official journal of the European Hematology Association), “evidence suggests that nilotinib has a propensity to increase the risk of occlusive cardiovascular disease, especially in patients with pre-existing cardiovascular risk factors.
Tasigna is a second-generation tyrosine kinase inhibitor (TKI) medication that’s approved to Philadelphia-positive chronic myeloid leukemia (Ph+ CML) patients.
Had the doctor intervened at the first sign of symptoms with therapy, the plaintiff’s life may have been spared.
FDA (2017) “Tasigna: Highlights of Prescribing Information” Health Canada (2013) “TASIGNA (nilotinib) — Potential Risk of Developing Atherosclerosis-Related Conditions — To the Public” Heart Org (2017) “Atherosclerosis” Tasigna Lawsuit Documents Point to Company Wrongdoing.
Studies have shown a link between the Tasigna and atherosclerosis.
Tasigna Lawsuit FAQs.
WASHINGTON, D.C. (Feb.
Consequently, more and more people will continue to experience side effects and these dangers.
DrugNews functions only with lawyers and law firms that have handled thousands of defective drug and medical device lawsuits.
Knightline Legal: Tasigna.
8 billion in sales of this cancer drug.
Visit for more information.
(Case No. No. 16-393) The reason for the increasing number of Tasigna lawsuit.
— Case No. 16-393.
Tasigna is a product of Novartis AG Pharmaceutical, a giant company based out of Switzerland.
Due to this, the arteries become swelled resulting in troubles, limb amputation, and death.
Lawyers Helping Virginia Families Harmed by Tasigna Atherosclerosis & Peripheral Arterial Disease.
Virginia Tasigna atherosclerosis lawsuits allow individuals to seek compensation for the medical expenses, pain and suffering that have resulted from this dangerous drug.
Hence, their family members or the patients are eligible to get the reimbursement.
Considering Tasigna atherosclerosis research from the U.S., Europe and Canada, as well as adverse event reports filed in the U.S., the FDA wrote its findings \”strongly suggest an association between nilotinib (Tasigna) and PAOD (peripheral vascular occlusive disease)\”.
Filing a Tasigna lawsuit may be an option for patients who developed arteriosclerosis when taking this cancer medication, particularly if the condition resulted in heart attack, cardiovascular disease, stroke, amputations, or death.
These Virginia Tasigna lawyers will offer a free case review to relatives and persons of persons who were harmed by Tasigna.
The business was accused of engaging in an aggressive marketing campaign with promises that were false and omitting risk information to market Tasigna over leukemia treatments.
Novartis might have misled the public and American cancer doctors when it attracted Tasigna to the marketplace. . .
Research suggests a link between using Tasigna to treat chronic myeloid leukemia (CML) and atherosclerosis, a disease that causes the arteries to thicken and harden due to the buildup of plaque.
Various studies have alleged that the drug Tasigna has serious undisclosed side effects that have irreversible and life threatening conditions, such as atherosclerosis, that can result in the following: Allegations suggest that Tasigna causes atherosclerosis, which is a thickening of the arterial walls, narrowing the arteries and building up expansion of a fibrofatty plaque, which ultimately can lead to peripheral arterial disease (PAD).
} To date no one has organized cases into one Tasigna class action lawsuit.
Atherosclerosis and Side Effects.
At precisely the same time that it released this statement, Health Canada announced changes would be made to reflect these findings and the potential risk.
The first of those Tasigna atherosclerosis studies was published back in 2011, just four years after the drug was approved.
However, this is typical of most types of lawsuits.
Life-extending cancer chemotherapy drug Gleevec went off patent in July 2015 and Tasigna rushed to market. . .
Visit for more information.
A drug used to treat a rare kind of blood cancer, Tasigna, has been linked to atherosclerosis.